Long-term subcutaneous and oral anticoagulants after acute coronary syndromes.
Antithrombotic treatment of acute coronary syndrome consists of aspirin and (low-molecular weight) heparin, whereas oral glycoprotein IIb/IIIa receptor antagonists as a routine cannot be advised and thrombolytic therapy is not indicated at all. Long-term protection also consists of antiplatelet therapy and, if indicated, by anticoagulant therapy, given either as low-molecular weight heparin or as oral anticoagulants.
University Medical Center St. Radboud, Nijmegen, The Netherlands.
Freek W
FW
Verheugt
D000208:Acute Disease; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007279:Injections, Subcutaneous; D013577:Syndrome; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents